CN1318049C - Medicine for treating psoriasis - Google Patents
Medicine for treating psoriasis Download PDFInfo
- Publication number
- CN1318049C CN1318049C CNB2004100602712A CN200410060271A CN1318049C CN 1318049 C CN1318049 C CN 1318049C CN B2004100602712 A CNB2004100602712 A CN B2004100602712A CN 200410060271 A CN200410060271 A CN 200410060271A CN 1318049 C CN1318049 C CN 1318049C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- fructus
- treatment
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a medicine for treating psoriasis, which is prepared from the raw materials of 15 to 60 shares of angelica, 12 to 36 shares of safflower, 15 to 60 shares of aspongopus, 15 to 60 shares of ledebouriella root, 15 to 60 shares of alkanna tinctoria and 15 to 60 of belvedere fruit. The present invention has the advantages of wide medicine sources and low cost. By the clinical verification, the toxic and side effects are little, the cure rate is high, and the treatment effect on seborrheic dermatitis is obvious.
Description
Technical field:
The present invention relates to a kind of Chinese medicine composition, the psoriatic medicine of a kind of specifically treatment.
Background technology:
Psoriasis claims " psoriasis " again, is a kind of human body immune disease of common easy recurrence, and clinical manifestation is erythema, pimple or the chickenpox that distributes on the skin and differ in size, and covers silvery white squama, and anti-dandruff have an ecchymosis etc.; Modern medicine thinks that its cause of disease is heredity, infection, variation, autoimmune etc., and sick mechanism mostly is the temperament and interest internal injury, excessive fire in heart, failure of skin and muscle to be nourished, damp and hot can not be excessive etc.; China patient's characteristic distributions be the male more than the women, excellent in the majority with person between twenty and fifty, show domestic patient about about 3,000,000 according to data.At present the treatment of this disease is not still had specific drug, use the external preparation for skin medicine, more though disease takes a turn for the better to some extent, but DeGrain, easily recurrence, Western medicine is used bimolane, etretinate etc. more, and these medicines also possess certain curative effect, but also possess certain toxic and side effects, usually damage organs such as liver, kidney.
Summary of the invention:
The present invention is directed to above deficiency and provide that a kind of toxic and side effects is little, good effect, the psoriatic medicine of treatment that cost is low.
(by weight) that the present invention has the raw material of following component to make:
Radix Angelicae Sinensis 15-60 Flos Carthami 12-36 Aspongopus 15-60
Radix Saposhnikoviae 15-60 Radix Arnebiae (Radix Lithospermi) 15-60 Fructus Kochiae 15-60
Its best proportioning is:
Radix Angelicae Sinensis 50 Flos Carthamis 30 Aspongopuss 50
Radix Saposhnikoviae 50 Radix Arnebiae (Radix Lithospermi)s 50 Fructus Kochiae 50
For reaching effect more, also can add in the medicine of the present invention:
Herba Portulacae 24-90 Endothelium Corneum Gigeriae Galli 10-40 Radix Cynanchi Paniculati 12-36
Grey sub-12-36 Cortex Pseudolaricis 12-36 Fructus Tribuli 15-80
Radix Aucklandiae 12-36 Fructus Cnidii 15-60 Zaocys 12-36
Preferential proportioning:
Herba Portulacae 75 Endothelium Corneum Gigeriae Galli 30 Radix Cynanchi Paniculatis 30
Grey sub 30 Cortex Pseudolaricis, 30 Fructus Tribulis 50
The Radix Aucklandiae 30 Fructus Cnidiis 50 Zaocyss 30
The present invention is a monarch drug with Radix Angelicae Sinensis, Flos Carthami, Aspongopus, has effects such as blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain, blood circulation promoting, endocrine regulation; The effect that has clearing away heat from blood, separates pyretic toxicity in league with ministerial drug Radix Saposhnikoviae, Radix Arnebiae (Radix Lithospermi), the Fructus Kochiae; Attached have an effect that helps digestion, removes rheumatism, separates sore, anti-tinea miliaria with Herba Portulacae, Endothelium Corneum Gigeriae Galli, Radix Cynanchi Paniculati, grey son, Cortex Pseudolaricis, Fructus Tribuli, the Radix Aucklandiae, Fructus Cnidii, Zaocys.The present invention can make any dosage form on the Chinese materia medica, and the present invention also has obvious curative effects to seborrheic dermatitis.
Medicine of the present invention source is extensive, with low cost, and is little through the clinical verification toxic and side effects, curative effect is obvious,, clinical data is as follows:
1, case choice criteria: selecting 40 examples is object of study, wherein male 28 examples, women 12 examples; Age minimum 16, maximum 48, mean age 36; Average course of disease 2.6 years.
2, treatment standard:
Cure: deflorescence, erythema disappear, the silver bits come off, skin recovers normal, and no new erythema occurs;
Produce effects: erythra, erythema disappearance 50-70%, do not find that new erythema occurs;
Effectively: erythra, erythema disappearance 10-30%, do not find that new erythema occurs;
Invalid: erythra, erythema are not seen disappearance, or enlargement phenomenon is arranged.
3, administrated method:
Take by weighing raw material by subordinate's proportioning:
Radix Angelicae Sinensis 50 Flos Carthamis 30 Aspongopuss 50
Radix Saposhnikoviae 50 Radix Arnebiae (Radix Lithospermi)s 50 Fructus Kochiae 50
Herba Portulacae 75 Endothelium Corneum Gigeriae Galli 30 Radix Cynanchi Paniculatis 30
Grey sub 30 Cortex Pseudolaricis, 30 Fructus Tribulis 50
The Radix Aucklandiae 30 Fructus Cnidiis 50 Zaocyss 30
Decoction, once a day, morning or evening, three days one pair of medicines, 60 days one courses of treatment.
4, therapeutic effect, contrast test and conclusion:
The treatment group:
| Case (40) | Cure | Produce effects | Effectively | Invalid |
| Number (people) | 32 | 6 | 1 | 1 |
| Ratio (%) | 80 | 15 | 2.5 | 2.5 |
Select medical history, the state of an illness, the age patient suitable with sex to form contrast groups, be equipped with external used medicine with Germany 606, used one month, curative effect is as follows:
| Case (40) | Cure | Produce effects | Effectively | Invalid |
| Number (people) | 24 | 6 | 2 | 8 |
| Ratio (%) | 60 | 15 | 5 | 20 |
With untoward reaction, people's permanent disability, and recurrence is arranged.
As seen: treatment effective percentage 97.5%, and how take effect in 40 days in treatment, period in a medicine finds no toxic and side effects, does not see recurrence in 8 years.The result shows that medication effect of the present invention is good, and toxic and side effects is little, and relapse rate is low.
The specific embodiment:
Embodiment 1:
Radix Angelicae Sinensis 50 Flos Carthamis 30 Aspongopuss 50
Radix Saposhnikoviae 50 Radix Arnebiae (Radix Lithospermi)s 50 Fructus Kochiae 50
Herba Portulacae 75 Endothelium Corneum Gigeriae Galli 30 Radix Cynanchi Paniculatis 30
Grey sub 30 Cortex Pseudolaricis, 30 Fructus Tribulis 50
The Radix Aucklandiae 30 Fructus Cnidiis 50 Zaocyss 30
The common process decoction gets final product.
Embodiment 2:
Radix Angelicae Sinensis 15 Flos Carthamis 12 Aspongopuss 15
Radix Saposhnikoviae 15 Radix Arnebiae (Radix Lithospermi)s 15 Fructus Kochiae 15
Herba Portulacae 18 Endothelium Corneum Gigeriae Galli 12 Radix Cynanchi Paniculatis 12
Grey sub 12 Cortex Pseudolaricis, 12 Fructus Tribulis 15
The Radix Aucklandiae 12 Fructus Cnidiis 15 Zaocyss 12
Common process decoction, number of times double to get final product
Embodiment 3:
Radix Angelicae Sinensis 60 Flos Carthamis 45 Aspongopuss 75
Radix Saposhnikoviae 60 Radix Arnebiae (Radix Lithospermi)s 50 Fructus Kochiae 60
Herba Portulacae 75 Endothelium Corneum Gigeriae Galli 40 Radix Cynanchi Paniculatis 36
Grey sub 30 Cortex Pseudolaricis, 36 Fructus Tribulis 60
The Radix Aucklandiae 36 Fructus Cnidiis 60 Zaocyss 36
The common process decoction gets final product.
Claims (6)
1, the psoriatic medicine of a kind of treatment is characterized in that: mainly be made up of the medicine of following composition by weight:
Radix Angelicae Sinensis 50 Flos Carthamis 30 Aspongopuss 50
Radix Saposhnikoviae 50 Radix Arnebiae (Radix Lithospermi)s 50 Fructus Kochiae 50.
2, the psoriatic medicine of a kind of treatment as claimed in claim 1 is characterized in that: the medicine that also adds following composition by weight:
Herba Portulacae 75 Endothelium Corneum Gigeriae Galli 30 Radix Cynanchi Paniculatis 30
Grey sub 30 Cortex Pseudolaricis, 30 Fructus Tribulis 50
The Radix Aucklandiae 30 Fructus Cnidiis 50 Zaocyss 30.
3, the psoriatic medicine of a kind of treatment is characterized in that: mainly be made up of the medicine of following composition by weight:
Radix Angelicae Sinensis 15 Flos Carthamis 12 Aspongopuss 15
Radix Saposhnikoviae 15 Radix Arnebiae (Radix Lithospermi)s 15 Fructus Kochiae 15.
4, the psoriatic medicine of a kind of treatment as claimed in claim 3 is characterized in that: the medicine that also adds following composition by weight:
Herba Portulacae 24 Endothelium Corneum Gigeriae Galli 10 Radix Cynanchi Paniculatis 12
Grey sub 12 Cortex Pseudolaricis, 12 Fructus Tribulis 15
The Radix Aucklandiae 12 Fructus Cnidiis 15 Zaocyss 12.
5, the psoriatic medicine of a kind of treatment is characterized in that: mainly be made up of the medicine of following composition by weight:
Radix Angelicae Sinensis 60 Flos Carthamis 36 Aspongopuss 60
Radix Saposhnikoviae 60 Radix Arnebiae (Radix Lithospermi)s 60 Fructus Kochiae 60.
6, the psoriatic medicine of a kind of treatment as claimed in claim 5 is characterized in that: the medicine that also adds following composition by weight:
Herba Portulacae 90 Endothelium Corneum Gigeriae Galli 40 Radix Cynanchi Paniculatis 36
Grey sub 36 Cortex Pseudolaricis, 36 Fructus Tribulis 80
The Radix Aucklandiae 36 Fructus Cnidiis 60 Zaocyss 36.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100602712A CN1318049C (en) | 2004-11-22 | 2004-11-22 | Medicine for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100602712A CN1318049C (en) | 2004-11-22 | 2004-11-22 | Medicine for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634306A CN1634306A (en) | 2005-07-06 |
| CN1318049C true CN1318049C (en) | 2007-05-30 |
Family
ID=34846225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100602712A Expired - Fee Related CN1318049C (en) | 2004-11-22 | 2004-11-22 | Medicine for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1318049C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101428097B (en) * | 2008-11-12 | 2011-09-07 | 黄相辉 | Psoriasis treating Chinese medicine preparation and its preparing process |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172674A (en) * | 1997-08-29 | 1998-02-11 | 刘进成 | Chinese medicinal herb composition for treating skin disease |
| CN1451405A (en) * | 2002-04-16 | 2003-10-29 | 亓新国 | Chinese medicine plaster for treating psoriasis |
-
2004
- 2004-11-22 CN CNB2004100602712A patent/CN1318049C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172674A (en) * | 1997-08-29 | 1998-02-11 | 刘进成 | Chinese medicinal herb composition for treating skin disease |
| CN1451405A (en) * | 2002-04-16 | 2003-10-29 | 亓新国 | Chinese medicine plaster for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1634306A (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066442A (en) | Externally applied Chinese medicine lotion for treating pain caused by wind, cold and damp | |
| CN102319327A (en) | Traditional Chinese medicine for internally and externally treating diabetic foot | |
| CN104587050B (en) | A kind of Chinese medicinal body slim patch and preparation method thereof | |
| CN101897882B (en) | Medicament for treating and breast lobular hyperplasia and cyst | |
| CN1977899B (en) | Medicine for treating rheumatoid arthritis | |
| CN101116712A (en) | Drug for curing cerebral infarction --- liquid for promoting blood circulation and removing blood stasis | |
| CN103463467B (en) | A kind of seedling prescription wine with nourishing kidney yin | |
| CN102836338B (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
| CN108498772A (en) | Medical moxibustion composition and preparation method thereof for whole body conditioning | |
| CN1318049C (en) | Medicine for treating psoriasis | |
| CN103830591A (en) | Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine | |
| CN104922383B (en) | One improves myocardial ischemia and ARR compositions | |
| CN104547222A (en) | Traditional Chinese medicine patching agent for treating hyperostosis | |
| CN1136870C (en) | Medicine for treating rheumatism | |
| CN104055925A (en) | Traditional Chinese medicine composition for treating diabetic peripheral neuropathy | |
| CN116492412B (en) | Traditional Chinese medicine composition for treating peripheral neuritis with blood deficiency and collateral obstruction syndrome | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN105853635A (en) | Pharmaceutical composition for treating angina pectoris of coronary heart disease | |
| CN105106855A (en) | Traditional Chinese medicine preparation for treating apoplexy sequela | |
| CN103845499B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
| CN104225435A (en) | Traditional Chinese medicine preparation for treating turbid phlegm obstructing type coronary heart disease | |
| CN103961589A (en) | Traditional Chinese medicine preparation for treating epilepsy and preparation method thereof | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070530 Termination date: 20091222 |